参考文献/References:
[1]孔玉方，杨毅梅. 纳米佐剂疫苗的特点与应用[J].医药导报，2017(6)：654-658.
[2]赵思俊，孙晓亮，曲志娜，等. 新型免疫佐剂研究进展[J].中国动物检疫，2016(7)：58-61.
[3]PEGGY R，KAI S，THOMAS E，et al. Vaccine adjuvants：Key tools for innovative vaccine design[J]. Current Topics in Medicinal Chemistry，2013，13(20)：2562-2580.
[4]ANDERSON J M，SHIVE M S. Biodegradation and biocompatibility of PLA and PLGA microspheres[J]. Advanced Drug Delivery Reviews，2012，64：72-82.
[5]TREGONING J S，RUSSELL R F，KINNEAR E. Adjuvanted influenza vaccines[J]. Human Vaccines & Immunotherapeutics，2017，12：1-15.
[6]LUO L，ZHENG S，HUANG Y，et al. Preparation and characterization of Chinese yam polysaccharide PLGA nanoparticles and their immunological activity[J]. International Journal of Pharmaceutics，2016，511：140-150.
[7]SUN B，XIA T. Nanomaterial-based vaccine adjuvants[J]. Journal of Materials Chemistry B，2016，10：5496-5509.
[8]李林芝，刘梅，常颖. 姜黄素-PLGA纳米粒温敏原位凝胶的制备及其在兔眼房水中的药动学研究[J].中国药房，2018，29(5)：640-643.
[9]MIR M，AHMED N，UR-REHMAN A. Rehman， recent applications of PLGA based nanostructures in drug delivery[J]. Colloids and Surfaces B：Biointerfaces，2017，159：217-231.
[10]RATZINGER G，FILLAFER C，KERLETA V，et al. The role of surface functionalization in the design of PLGA micro and nanoparticles[J]. Critical Reviews in Therapeutic Drug Carrier Systems，2010，27(1)：70-83.
[11]王珊，花亚冰，高翔，等. 注射用乳酸-羟基乙酸共聚物微球的体内外相关性研究进展[J].药学学报，2020，56(1)：158-168.
[12]GENTILE P，CHIONO V，CARMAGNOLA I，et al. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering[J]. International Journal of Molecular Sciences，2014，15(3)：3640-3659.
[13]MAKADIA H K，SIEGEL S J. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier[J]. Polymers，2011，3(4)：1377-1397.
[14]CRUZ L J，TACKEN P J，EICH C，et al. Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity[J]. Nanomedicine，2017，12(5)：491-510.
[15]王健群，张斌. 聚乳酸-羟基乙酸共聚物微球在骨组织工程中的应用[J].口腔医学研究，2020(9)：817-820.
[16]MUNDARGI R C，BABU V R，RANGASWAMY V，et al. Nano/micro technologies for delivering macromolecular therapeutics using poly(D，L-lactide-co-glycolide) and its derivatives[J]. Journal of Controlled Release，2008，125(3)：193-209.
[17]SHARMA S，PARMAR A，KORI S，et al. PLGA-based nanoparticles：A new paradigm in biomedical applications[J]. TrAC Trends in Analytical Chemistry，2015，80：30-40.
[18]MIRAKABAD F S T，NEJATI-KOSHKI K，AKBARZADEH A，et al. PLGA-based nanoparticles as cancer drug delivery systems[J]. Asian Pacific Journal of Cancer Prevention，2014，15(2)：517-535.
[19]SOPPIMATH K S，AMINABHAVI T M，KULKARNI A R，et al. Biodegradable polymeric nanoparticles as drug delivery devices[J]. Journal of Controlled Release，2001，29：1-20.
[20]NIE H，LEE L Y，TONG H，et al. PLGA/chitosan composites from a combination of spray drying and supercritical fluid foaming techniques：New carriers for DNA delivery[J]. Journal of Controlled Release，2008，129(3)：207-214.
[21]CHOURASIYA V，BOHREY S，PANDEY A. Hydrochlorothiazide containing PLGA nanoparticles：Design，characterization，in-vitro drug release and release kinetic study[J]. Polymer Science，2015，57(6)：645-653.
[22]MARKOCIC E， BOTIC T， KAVCIC S，et al. In vitro degradation of poly (D，L lactide-co-glycolide) foams processed with supercritical fluids[J]. Industrial & Engineering Chemistry Research，2015，54(7)：2114-2119.
[23]HUANG W，ZHANG C M. Tuning the size of poly(lactic-co-glycolic acid) (PLGA) nanoparticles fabricated by nanoprecipitation[J]. Biotechnology Journal，2018,13(1)：10.
[24]LUO L，QIN T. Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo[J]. Drug Delivery，2017，24(1)：1099-1111.
[25]LI J，NEMES P，GUO J. Mapping intermediate degradation products of poly (lactic-co-glycolic acid) in vitro[J]. Journal of Biomedical Materials Research Part B：Applied Biomaterials，2018，106(3)：1129-1137.
[26]ZHONG Q，MAO Q，YAN J，et al. Real-time in situ monitoring of poly(lactide-co-glycolide) coating of coronary stents using electrochemical impedance spectroscopy[J]. Journal of Biomedical Materials Research Part B Applied Biomaterials，2015，103(3)：691-699.
[27]JALIL A H，PYELL U. Quantification of zeta-potential and electrokinetic surface charge density for colloidal silica nanoparticles dependent on type and concentration of the counterion：Probing the outer helmholtz plane[J]. Journal of Physical Chemistry C，2018，122(8)：4437-4453.
[28]SHI Y，XUE J，JIA L，et al. Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide[J]. Colloids & Surfaces B Biointerfaces，2018，161：67-72.
[29]GHALGAOUI A，DOUDIN N，KELDERER E，et al. 1，4-phenylene diisocyanide (PDI) interaction with low-coordinated gold sites：Dissociation and adsorbate-induced restructuring[J]. Journal of Physical Chemistry C，2019，123(13):7870-7878.
[30]YU Z，HUANG L，WEN R，et al. Preparation and in vivo pharmacokinetics of rhGH-loaded PLGA microspheres[J]. Pharmaceutical Development & Technology，2018，24(4)：1-7.
[31]LIU P，SUN L，LIU P，et al. Surface modification of porous PLGA scaffolds with plasma for preventing dimensional shrinkage and promoting scaffold-cell/tissue interactions[J]. Journal of Materials Chemistry B，2018，6：27-32.
[32]LU M，CHENG X Q，JIANG J Z，et al. Dual-modal photoacoustic and magnetic resonance tracking of tendon stem cells with PLGA/iron oxide microparticles in vitro[J]. PLoS One，2018，13(4):e0193362.
[33]JIE W，RUOCHEN W，NIANNIAN L，et al. High-performance reoxygenation from PLGA-PEG/PFOB emulsions：a feedback relationship between ROS and HIF-1α[J]. International Journal of Nanomedicine，2018，13:3027-3038.
[34]RAY S，RAY S G，MANDAL S. Development of bicalutamide-loaded PLGA nanoparticles：preparation，characterization and in-vitro evaluation for the treatment of prostate cancer[J]. Artificial Cells，2016，45(5)：1-11.
[35]HAFNER A M，CORTHESY B，TEXTOR M，et al. Surface-assembled poly(I：C) on PEGylated PLGA microspheres as vaccine adjuvant：APC activation and bystander cell stimulation[J]. International Journal of Pharmaceutics，2016，514(1)：176-188.
[36]LIU L，CAO F，LIU X，et al. Hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticles as a nanovaccine induce robust humoral and cellular immune responses[J]. ACS Applied Materials & Interfaces，2016，8(19)：11969-11979.
[37]ZHOU P，AN T，ZHAO C，et al. Lactosylated PLGA nanoparticles containing -polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins[J]. International Journal of Pharmaceutics，2015，478(2)：633-643.
[38]HAMDY S，MOLAVI O，MA Z，et al. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity[J]. Vaccine，2008，26(39)：5050-5057.
[39]LUO W H，YANG Y W. Activation of antigen-specific CD8+T cells by poly-DL-lactide/glycolide (PLGA) nanoparticle-primed gr-1high cells[J]. Pharmaceutical Research，2016，33(4)：942-955.
[40]DOLEN Y，KREUTZ M，GILEADI U，et al. Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses[J]. Oncoimmunology，2016，5(1):1-10.
[41]YU K，ZHAO J，ZHANG Z，et al. Enhanced delivery of paclitaxel using electrostatically-conjugated herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells[J]. International Journal of Pharmaceutics，2016，497(1)：78-87.
[42]HOWARD G P，VERMA G，KE X，et al. Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration[J]. Nano Research，2019,12(4)：12-18.
[43]AN M，LI M，XI J，et al. Silica nanoparticle as a lymph node targeting platform for vaccine delivery[J]. ACS Applied Materials & Interfaces，2017，9(28)：23466-23475.
[44]GUTIERRO I， HERNANDEZ R M，IGARTUA M，et al. Size dependent immune response after subcutaneous，oral and intranasal administration of BSA loaded nanospheres[J]. Vaccine，2002，21：67-77.
[45]GU P，XU S，ZHOU S，et al. Optimization of angelica sinensis polysaccharide-loaded Poly (lactic-co-glycolicacid) nanoparticles by RSM and its immunological activity in vitro[J]. International Journal of Biological Macromolecules，2017，107：222-229.
[46]WUSIMAN A，GU P，LIU Z，et al. Cationic polymer modified PLGA nanoparticles encapsulating alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses[J]. International Journal of Nanomedicine，2019,14：3221-3234.
[47]CHEN X，LIU Y，WANG L，et al. Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg[J]. Molecular Pharmaceutics，2014，11(6)：1772-1784.
[48]LIM H J，KIM J K，PARK J S. Complexation of apoptotic genes with polyethyleneimine (PEI)-Coated Poly-(DL)-Lactic-Co-Glycolic acid nanoparticles for cancer cell apoptosis[J]. Journal of Biomedical Nanotechnology，2015，11(2)：211-225.
[49]KANG B S，CHOI J S，LEE S E，et al. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles[J]. Carbohydrate Polymers，2016，159：39-47.
[50]LEE S Y，JUNG E，PARK J H，et al. Transient aggregation of chitosan-modified poly(D,L-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency[J]. Journal of Colloid and Interface Science，2016，480：102-108.
[51]ROSE F，WERN J E，GAVINS F，et al. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522[J]. Journal of Controlled Release，2018，271：88-97.
[52]SONG C，NOH Y W，LIM Y T. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response[J]. International Journal of Nanomedicine，2016，11：3753-3764.
[53]NIIKURA K，MATSUNAGA T，SUZUKI T，et al. Gold nanoparticles as a vaccine platform：influence of size and shape on immunological responses in vitro and in vivo[J]. ACS Nano，2013，7(5)：3926-3938.
[54]BENNE N，VAN-DUIJN J，KUIPER J，et al. Orchestrating immune responses：How size，shape and rigidity affect the immunogenicity of particulate vaccines[J]. Journal of Controlled Release，2016，234：124-134.
[55]SHAO K，SINGHA S，CLEMENTE-CASARES X，et al. Nanoparticle-based immunotherapy for cancer[J]. Acs Nano，2015，9(1)：16-30.
[56]LOZOYA-AGULLO I，ARAUJO F，GONZALEZ-ALVAREZ I，et al. PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen[J]. European Journal of Pharmaceutical Sciences，2018，115：119-128.
[57]QI F，WU J，SUN G，et al. Systematic studies of pickering emulsions stabilized by uniform-sized PLGA particles：preparation and stabilization mechanism[J]. Journal of Materials Chemistry，2014，2(43)：7605-7611.
[58]WUSIMAN A，GU P，LIU Z，et al. Cationic polymer modified PLGA nanoparticles encapsulating alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses[J]. International Journal of Nanomedicine，2019(14):3221-3234.
[59]MARTISKA J，SNEJDROVA E，DRASTIK M，et al. Terbinafine-loaded branched PLGA-based cationic nanoparticles with modifiable properties[J]. Pharmaceutical Development and Technology，2019，24(8)：1-32.
[60]XIA Y，WU J，WEI W，et al. Exploiting the pliability and lateral mobility of pickering emulsion for enhanced vaccination[J]. Nature Materials，2018，17：187-194.
[61]SONG Y C，CHENG H Y，LENG C H，et al. A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity[J]. Journal of Controlled Release，2014，173：158-165.